Trademarkia Logo

Canada

C$
ABKIBIT
ADVERTISED

on 1 Jan 2025

Last Applicant/ Owned by

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

68 XINQING ROAD,SUZHOU INDUSTRIAL PARK,SUZHOU215000 JIANGSU

CN

Serial Number

2200496 filed on 29th Jan 2022

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

CA

M5A0P6

ABKIBIT

Trademark usage description

chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related disea Read More

Classification Information


Class [005]
Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, agerelated diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; hemorrhoidal suppositories, laxative suppositories, and vaginal suppositories for the prevention and treatment of infections; medicated plasters; diagnostic preparations for medical purposes namely for use in cancer treatments; diagnostic biomarker reagents for medical purposes; Oil solutions for or use in the treatment of cancer and tumors; mineral food supplements; nutritional supplements for use in the treatment of cancer and tumors; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes for use in the treatment of cancer and tumors; Gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; solutions for contact lenses; media for bacteriological cultures; Depuratives for use in the treatment of cancer and tumors; veterinary preparations for use in the treatment of cancer and tumors; pesticides; sanitary napkins; dental abrasives


Classification kind code

11

Mark Details


Serial Number

2200496

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 25th Nov 2024
Agent Changed
Submitted for opposition 22
on 6th Nov 2023
Search Recorded
Submitted for opposition 20
on 6th Nov 2023
Examiner's First Report
Submitted for opposition 223
on 6th Nov 2023
Total Provisional Refusal
Submitted for opposition 256
on 29th May 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Jul 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 27th Jul 2022
Formalized
Submitted for opposition 1
on 27th Jul 2022
Created
Submitted for opposition 228
on 29th Jan 2022
International Registration
Submitted for opposition 30
on 29th Jan 2022
Filed